查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1888702

霉浆菌检测市场规模、份额和趋势分析（按产品、技术、应用、最终用途、地区和细分市场预测，2025-2033 年）

Mycoplasma Testing Market Size, Share & Trends Analysis By Product, By Technology, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

霉浆菌检测市场摘要

2024年全球霉浆菌检测市场规模估计为10.3亿美元，预计2033年将达28.1亿美元。

预计从 2025 年到 2033 年，该市场将以 11.94% 的复合年增长率成长。生命科学领域研发投入的增加是推动市场成长的主要因素。

製药公司愿意投入大量资源开发生物製剂和生物相似药，而这些药物需要严格的污染控制。例如，百时美施贵宝公司正在大力投资临床实验新药，以支持其不断扩大的临床试验计画组合。

与其他产业相比，生物製药及相关市场受新冠肺炎疫情的影响较小。一项发表于2022年5月的研究发现，霉浆菌检测量与新冠肺炎相关的非药物干预措施（NPIs）之间存在相关性。该研究分析了新冠肺炎非药物干预措施实施后肺炎支原体的感染率。研究发现，疫情期间霉浆菌的霉浆菌下降，2020年3月至2021年3月期间全球均出现下降。这一下降主要归因于霉浆菌传播受到限制，导致全球霉浆菌霉浆菌感染疾病显着减少。

随着生物製药和疫苗生产的扩张，生产商需要可靠的霉浆菌检测解决方案，以确保产品的纯度、安全性和合规性。因此，对先进检测套组的需求日益增长。此外，随着越来越多的生物製药进入临床开发阶段，维持无污染的细胞培养变得至关重要，这也增加了对严格霉浆菌检测的需求。检测技术的持续创新有望带来更快、更灵敏、更经济高效的检测方法，以满足製药业不断增长的需求。

全球公共卫生措施的日益重视以及疫苗需求的成长预计将推动市场强劲成长。为支持此趋势，各大製药公司持续增加对生物製造基础设施的投资。例如，默克公司于2025年10月宣布，将投资30亿美元，在其位于维吉尼亚埃尔克顿的工厂建设一座占地40万平方英尺的製药生产设施。这项重大投资凸显了製药业为扩大疫苗和生物製药产能以满足全球需求所做的努力。

目录

第一章调查方法和范围

第二章执行摘要

第三章 市场变数、趋势与范围

  • 市场区隔和范围
  • 市场体系展望
    • 母市场展望
    • 相关及附随市场展望
  • 市场趋势与展望
  • 市场动态
  • 市场限制因素分析
    • 细胞生物学研究成本高昂
    • 霉浆菌培养生长速度缓慢
  • 机会分析
  • 当前及未来市场趋势
  • 商业环境分析
    • SWOT分析：依因素（政治/法律、经济、技术）划分
    • 波特五力分析
  • 新冠疫情影响分析
  • Mekkochart 在霉浆菌检测市场的产品排名
  • Mekkochart 在霉浆菌检测市场的检测方法

第四章：依产品进行业务分析

  • 霉浆菌检测市场：按产品分類的波动分析
  • 装置
  • 试剂盒和试剂
    • PCR检测
    • 核酸检测试剂盒
    • 染料
    • 拆卸工具包
    • 标准与控制
    • 其他的
  • 服务

第五章：依技术进行业务分析

  • 霉浆菌检测市场：依技术分類的差异分析
  • PCR
  • ELISA
  • 直接检测法
  • 间接检测
  • 微生物培养技术
  • 酵素法

第六章：按应用程式进行业务分析

  • 霉浆菌检测市场：依应用领域分析波动状况
  • 细胞株检测
  • 病毒检测
  • 停止细胞测试
  • 其他的

第七章 依最终用途进行业务分析

  • 霉浆菌检测市场：依最终用途分類的差异分析
  • 製药和生物技术公司
  • 细胞库
  • 受託研究机构
  • 学术和研究机构
  • 其他的

第八章：区域商业分析

  • 2024 年及 2033 年各地区霉浆菌检测市场占有率
  • 北美洲
    • SWOT分析
    • 2021-2033年北美霉浆菌检测市场
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • SWOT分析
    • 2021-2033年欧洲霉浆菌检测市场
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • SWOT分析
    • 亚太地区霉浆菌检测市场，2021-2033年
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • SWOT分析
    • 2021-2033年拉丁美洲霉浆菌检测市场
    • 巴西
    • 阿根廷
  • 中东和非洲
    • SWOT分析
    • 2021-2033年中东及非洲霉浆菌检测市场
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争情势

  • 公司分类
  • 策略规划
  • 主要企业市占率分析（2024 年）
  • 公司简介
    • Thermo Fisher Scientific, Inc.
    • Merck &Co., Inc.
    • Lonza Group AG
    • Charles River Laboratories International, Inc.
    • PromoCell GmbH
    • Asahi Kasei Medical Co., Ltd.
    • Sartorius AG
    • InvivoGen
    • Eurofins Scientific
    • （ATCC）American Type Culture Collection
Product Code: GVR-1-68038-897-8

Mycoplasma Testing Market Summary

The global mycoplasma testing market size was estimated at USD 1.03 billion in 2024 and is expected to reach USD 2.81 billion in 2033, growing at a CAGR of 11.94% from 2025 to 2033. The rising investments in research and development (R&D) across the life sciences sector are a significant market driver.

Pharmaceutical companies are actively channeling substantial resources into biopharmaceutical and biosimilar development, which requires stringent contamination control. For instance, Bristol-Myers Squibb has invested heavily in the production of investigational medicines to support its expanding portfolio of clinical trials.

The biopharmaceutical and related markets have not been significantly impacted by the COVID-19 pandemic when compared to other industries. According to a study published in May 2022, there is a correlation between mycoplasma testing numbers and COVID-19-related Non-Pharmaceutical Interventions (NPIs). This study analyzed the incidence of M. pneumonia after the implementation of COVID-19 NPIs. This survey showed that there has been a decrease in M. pneumoniae detection during the pandemic, and a reduction was observed globally between March 2020 and March 2021. The reduction is majorly due to restricted transmission of M. pneumonia, resulting in a significant reduction in M. pneumoniae infections across the globe.

As biopharmaceutical and vaccine production scales up, manufacturers require reliable mycoplasma testing solutions to ensure the purity, safety, and regulatory compliance of their products. Consequently, the need for advanced testing kits has intensified. Moreover, as more biologics advance through clinical development, maintaining uncontaminated cell cultures becomes critical, thereby increasing the demand for rigorous mycoplasma testing. Ongoing innovations in detection technologies are also expected to yield faster, more sensitive, and cost-effective testing methods that align with the growing requirements of the pharmaceutical industry.

The rising global emphasis on public health preparedness and the expanding demand for vaccines are expected to drive strong market growth. Supporting this trend, leading pharmaceutical companies continue to invest heavily in biomanufacturing infrastructure. For example, in October 2025, Merck & Co., Inc. announced the start of construction on a USD 3 billion, 400,000-square-foot pharmaceutical manufacturing facility at its Elkton, Virginia site. This major investment underscores the industry's commitment to expanding vaccine and biologics production capacity to meet global demand.

Global Mycoplasma Testing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global mycoplasma testing market report based on product, technology, application, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Instruments
  • Kits & Reagents
    • PCR Assays
    • Nucleic Acid Detection Kits
    • Stains
    • Elimination Kits
    • Standards & Controls
    • Others
  • Services
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • PCR
  • ELISA
  • Direct Assay
  • Indirect Assay
  • Microbial Culture Techniques
  • Enzymatic Methods
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Cell Line Testing
  • Virus Testing
  • End of Production Cells Testing
  • Others
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Academic Research Institutes
  • Cell Banks
  • Contract Research Organizations
  • Pharmaceutical & Biotechnology Companies
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Spain
    • France
    • Italy
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Thailand
    • Australia
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1 Market Segmentation and Scope
    • 1.1.1 Segment Definitions
      • 1.1.1.1 Test Segment
      • 1.1.1.2 Service Provider Segment
      • 1.1.1.3 Application Segment
  • 1.2 Regional Scope
  • 1.3 Estimates and Forecast Timeline
  • 1.4 Objectives
    • 1.4.1 Objective - 1
    • 1.4.2 Objective - 2
    • 1.4.3 Objective - 3
  • 1.5 Research Methodology
  • 1.6 Information Procurement
    • 1.6.1 Purchased Database
    • 1.6.2 Gvr's Internal Database
    • 1.6.3 Secondary Sources
    • 1.6.4 Primary Research
  • 1.7 Information or Data Analysis
    • 1.7.1 Data Analysis Models
  • 1.8 Market Formulation & Validation
  • 1.9 Model Details
    • 1.9.1 Commodity Flow Analysis
  • 1.10 List of Secondary Sources
  • 1.11 List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Trends and Outlook
  • 3.4. Market Dynamics
    • 3.4.1. Increasing R&D investments in life sciences
    • 3.4.2. Rising government support toward pharmaceutical and biotechnology industries
    • 3.4.3. Growing demand for biopharmaceuticals and vaccines
    • 3.4.4. Rising cell culture contamination
  • 3.5. Market Restraint Analysis
    • 3.5.1. High cost of research in cell biology
    • 3.5.2. Slow rate of mycoplasma growth
  • 3.6. Opportunity Analysis
  • 3.7. Current and Future Market Trends:
  • 3.8. Business Environment Analysis
    • 3.8.1. SWOT Analysis: By Factor (Political & Legal, Economic, And Technological)
    • 3.8.2. Porter's Five Forces Analysis
  • 3.9. COVID-19 Impact Analysis
  • 3.10. Mekko Chart for Mycoplasma Testing Market, by Product
  • 3.11. Mekko Chart for Mycoplasma Testing Market, by Test Method

Chapter 4. Product Business Analysis

  • 4.1. Mycoplasma Testing Market: Product Movement Analysis
  • 4.2. Instruments
    • 4.2.1. Instruments Market, 2021 - 2033 (USD Million)
  • 4.3. Kits & Reagents
    • 4.3.1. Kits & Reagents Market, 2021 - 2033 (USD Million)
    • 4.3.2. PCR Assays
      • 4.3.2.1. PCR Assays Market, 2021 - 2033 (USD Million)
    • 4.3.3. Nucleic Acid Detection Kits
      • 4.3.3.1. Nucleic Acid Detection Kits Market, 2021 - 2033 (USD Million)
    • 4.3.4. Stains
      • 4.3.4.1. Stains Market, 2021 - 2033 (USD Million)
    • 4.3.5. Elimination Kits
      • 4.3.5.1. Elimination Kits Market, 2021 - 2033 (USD Million)
    • 4.3.6. Standards & Controls
      • 4.3.6.1. Standards & Controls Market, 2021 - 2033 (USD Million)
    • 4.3.7. Others
      • 4.3.7.1. Others Market, 2021 - 2033 (USD Million)
  • 4.4. Services
    • 4.4.1. Services Market, 2021 - 2033 (USD Million)

Chapter 5. Technology Business Analysis

  • 5.1. Mycoplasma Testing Market: Technology Movement Analysis
  • 5.2. PCR
    • 5.2.1. PCR Market, 2021 - 2033 (USD Million)
  • 5.3. ELISA
    • 5.3.1. ELISA Market, 2021 - 2033 (USD Million)
  • 5.4. Direct Assay
    • 5.4.1. Direct Assay Market, 2021 - 2033 (USD Million)
  • 5.5. Indirect Assay
    • 5.5.1. Indirect Assay Market, 2021 - 2033 (USD Million)
  • 5.6. Microbial Culture Techniques
    • 5.6.1. Microbial Culture Techniques Market, 2021 - 2033 (USD Million)
  • 5.7. Enzymatic Methods
    • 5.7.1. Enzymatic Methods Market, 2021 - 2033 (USD Million)

Chapter 6. Application Business Analysis

  • 6.1. Mycoplasma Testing Market: Application Movement Analysis
  • 6.2. Cell Line Testing
    • 6.2.1. Cell Line Testing Market, 2021 - 2033 (USD Million)
  • 6.3. Virus Testing
    • 6.3.1. Virus Testing Market, 2021 - 2033 (USD Million)
  • 6.4. End of Production Cells Testing
    • 6.4.1. End of Production Cells Testing Market, 2021 - 2033 (USD Million)
  • 6.5. Others
    • 6.5.1. Others Market, 2021 - 2033 (USD Million)

Chapter 7. End Use Business Analysis

  • 7.1. Mycoplasma Testing Market: End Use Movement Analysis
  • 7.2. Pharmaceutical & Biotechnology Companies
    • 7.2.1. Pharmaceutical & Biotechnology Companies Market, 2021 - 2033 (USD Million)
  • 7.3. Cell Banks
    • 7.3.1. Cell Banks Market, 2021 - 2033 (USD Million)
  • 7.4. Contract Research Organizations
    • 7.4.1. Contract Research Organizations Market, 2021 - 2033 (USD Million)
  • 7.5. Academic & Research Institutes
    • 7.5.1. Academic & Research Institutes Market, 2021 - 2033 (USD Million)
  • 7.6. Others
    • 7.6.1. Others Market, 2021 - 2033 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. Mycoplasma Testing Market Share By Region, 2024 & 2033
  • 8.2. North America
    • 8.2.1. SWOT Analysis
    • 8.2.2. North America Mycoplasma Testing Market, 2021 - 2033 (USD Million)
    • 8.2.3. U.S.
      • 8.2.3.1. Key Country Dynamics
      • 8.2.3.2. Target Disease Prevalence
      • 8.2.3.3. Competitive Scenario
      • 8.2.3.4. Regulatory Framework
      • 8.2.3.5. Reimbursement Scenario
      • 8.2.3.6. U.S. Mycoplasma Testing Market, 2021 - 2033 (USD MILLION)
    • 8.2.4. Canada
      • 8.2.4.1. Key Country Dynamics
      • 8.2.4.2. Target Disease Prevalence
      • 8.2.4.3. Competitive Scenario
      • 8.2.4.4. Regulatory Framework
      • 8.2.4.5. Reimbursement Scenario
      • 8.2.4.6. Canada Mycoplasma Testing Market, 2021 - 2033 (USD Million)
    • 8.2.5. Mexico
      • 8.2.5.1. Key Country Dynamics
      • 8.2.5.2. Target Disease Prevalence
      • 8.2.5.3. Competitive Scenario
      • 8.2.5.4. Regulatory Framework
      • 8.2.5.5. Reimbursement Scenario
      • 8.2.5.6. Mexico Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • 8.3. Europe
    • 8.3.1. SWOT Analysis
    • 8.3.2. Europe Mycoplasma Testing Market, 2021 - 2033 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Target Disease Prevalence
      • 8.3.3.3. Competitive Scenario
      • 8.3.3.4. Regulatory Framework
      • 8.3.3.5. Reimbursement Scenario
      • 8.3.3.6. Germany Mycoplasma Testing Market, 2021 - 2033 (USD Million)
    • 8.3.4. UK
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Target Disease Prevalence
      • 8.3.4.3. Competitive Scenario
      • 8.3.4.4. Regulatory Framework
      • 8.3.4.5. Reimbursement Scenario
      • 8.3.4.6. UK Mycoplasma Testing Market, 2021 - 2033 (USD Million)
    • 8.3.5. France
      • 8.3.5.1. Key Country Dynamics
      • 8.3.5.2. Target Disease Prevalence
      • 8.3.5.3. Competitive Scenario
      • 8.3.5.4. Regulatory Framework
      • 8.3.5.5. Reimbursement Scenario
      • 8.3.5.6. France Mycoplasma Testing Market, 2021 - 2033 (USD Million)
    • 8.3.6. Italy
      • 8.3.6.1. Key Country Dynamics
      • 8.3.6.2. Target Disease Prevalence
      • 8.3.6.3. Competitive Scenario
      • 8.3.6.4. Regulatory Framework
      • 8.3.6.5. Reimbursement Scenario
      • 8.3.6.6. Italy Mycoplasma Testing Market, 2021 - 2033 (USD Million)
    • 8.3.7. Spain
      • 8.3.7.1. Key Country Dynamics
      • 8.3.7.2. Target Disease Prevalence
      • 8.3.7.3. Competitive Scenario
      • 8.3.7.4. Regulatory Framework
      • 8.3.7.5. Reimbursement Scenario
      • 8.3.7.6. Spain Mycoplasma Testing Market, 2021 - 2033 (USD Million)
    • 8.3.8. Denmark
      • 8.3.8.1. Key Country Dynamics
      • 8.3.8.2. Target Disease Prevalence
      • 8.3.8.3. Competitive Scenario
      • 8.3.8.4. Regulatory Framework
      • 8.3.8.5. Reimbursement Scenario
      • 8.3.8.6. Denmark Mycoplasma Testing Market, 2021 - 2033 (USD Million)
    • 8.3.9. Sweden
      • 8.3.9.1. Key Country Dynamics
      • 8.3.9.2. Target Disease Prevalence
      • 8.3.9.3. Competitive Scenario
      • 8.3.9.4. Regulatory Framework
      • 8.3.9.5. Reimbursement Scenario
      • 8.3.9.6. Sweden Mycoplasma Testing Market, 2021 - 2033 (USD Million)
    • 8.3.10. Norway
      • 8.3.10.1. Key Country Dynamics
      • 8.3.10.2. Target Disease Prevalence
      • 8.3.10.3. Competitive Scenario
      • 8.3.10.4. Regulatory Framework
      • 8.3.10.5. Reimbursement Scenario
      • 8.3.10.6. Norway Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. SWOT Analysis
    • 8.4.2. Asia Pacific Mycoplasma Testing Market, 2021 - 2033 (USD Million)
    • 8.4.3. Japan
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Target Disease Prevalence
      • 8.4.3.3. Competitive Scenario
      • 8.4.3.4. Regulatory Framework
      • 8.4.3.5. Reimbursement Scenario
      • 8.4.3.6. Japan Mycoplasma Testing Market, 2021 - 2033 (USD Million)
    • 8.4.4. China
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Target Disease Prevalence
      • 8.4.4.3. Competitive Scenario
      • 8.4.4.4. Regulatory Framework
      • 8.4.4.5. Reimbursement Scenario
      • 8.4.4.6. China Mycoplasma Testing Market, 2021 - 2033 (USD Million)
    • 8.4.5. India
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Target Disease Prevalence
      • 8.4.5.3. Competitive Scenario
      • 8.4.5.4. Regulatory Framework
      • 8.4.5.5. Reimbursement Scenario
      • 8.4.5.6. India Mycoplasma Testing Market, 2021 - 2033 (USD Million)
    • 8.4.6. South Korea
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Target Disease Prevalence
      • 8.4.6.3. Competitive Scenario
      • 8.4.6.4. Regulatory Framework
      • 8.4.6.5. Reimbursement Scenario
      • 8.4.6.6. South Korea Mycoplasma Testing Market, 2021 - 2033 (USD Million)
    • 8.4.7. Australia
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Target Disease Prevalence
      • 8.4.7.3. Competitive Scenario
      • 8.4.7.4. Regulatory Framework
      • 8.4.7.5. Reimbursement Scenario
      • 8.4.7.6. Australia Mycoplasma Testing Market, 2021 - 2033 (USD Million)
    • 8.4.8. Thailand
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Target Disease Prevalence
      • 8.4.8.3. Competitive Scenario
      • 8.4.8.4. Regulatory Framework
      • 8.4.8.5. Reimbursement Scenario
      • 8.4.8.6. Thailand Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • 8.5. Latin America
    • 8.5.1. SWOT Analysis
    • 8.5.2. Latin America Mycoplasma Testing Market, 2021 - 2033 (USD Million)
    • 8.5.3. Brazil
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Target Disease Prevalence
      • 8.5.3.3. Competitive Scenario
      • 8.5.3.4. Regulatory Framework
      • 8.5.3.5. Reimbursement Scenario
      • 8.5.3.6. Brazil Mycoplasma Testing Market, 2021 - 2033 (USD Million)
    • 8.5.4. Argentina
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Target Disease Prevalence
      • 8.5.4.3. Competitive Scenario
      • 8.5.4.4. Regulatory Framework
      • 8.5.4.5. Reimbursement Scenario
      • 8.5.4.6. Argentina Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • 8.6. MEA
    • 8.6.1. SWOT Analysis
    • 8.6.2. MEA Mycoplasma Testing Market, 2021 - 2033 (USD Million)
    • 8.6.3. South Africa
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Target Disease Prevalence
      • 8.6.3.3. Competitive Scenario
      • 8.6.3.4. Regulatory Framework
      • 8.6.3.5. Reimbursement Scenario
      • 8.6.3.6. South Africa Mycoplasma Testing Market, 2021 - 2033 (USD Million)
    • 8.6.4. Saudi Arabia
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Target Disease Prevalence
      • 8.6.4.3. Competitive Scenario
      • 8.6.4.4. Regulatory Framework
      • 8.6.4.5. Reimbursement Scenario
      • 8.6.4.6. Saudi Arabia Mycoplasma Testing Market, 2021 - 2033 (USD Million)
    • 8.6.5. UAE
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Target Disease Prevalence
      • 8.6.5.3. Competitive Scenario
      • 8.6.5.4. Regulatory Framework
      • 8.6.5.5. Reimbursement Scenario
      • 8.6.5.6. UAE Mycoplasma Testing Market, 2021 - 2033 (USD Million)
    • 8.6.6. Kuwait
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Target Disease Prevalence
      • 8.6.6.3. Competitive Scenario
      • 8.6.6.4. Regulatory Framework
      • 8.6.6.5. Reimbursement Scenario
      • 8.6.6.6. Kuwait Mycoplasma Testing Market, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
    • 9.2.1. 10.2.1 New Product Launch
    • 9.2.2. 10.2.2 Partnerships
    • 9.2.3. 10.2.3 Acquisition
    • 9.2.4. 10.2.4 Collaboration
    • 9.2.5. 10.2.5 Funding
  • 9.3. Key Company Market Share Analysis, 2024
  • 9.4. Company Profiles
    • 9.4.1. Thermo Fisher Scientific, Inc.
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. Merck & Co., Inc.
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. Lonza Group AG
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. Charles River Laboratories International, Inc.
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. PromoCell GmbH
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. Asahi Kasei Medical Co., Ltd.
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. Sartorius AG
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. InvivoGen
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. Eurofins Scientific
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. (ATCC) American Type Culture Collection
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Mycoplasma Testing Market, by Region, 2021 - 2033 (USD Million)
  • Table 4 Global Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 5 Global Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 6 Global Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 7 Global Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 8 North America Mycoplasma Testing Market, by Country, 2021 - 2033 (USD Million)
  • Table 9 North America Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 10 North America Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 11 North America Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 12 North America Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 13 U.S. Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 14 U.S. Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 15 U.S. Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 16 U.S. Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 17 Canada Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 18 Canada Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 19 Canada Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 20 Canada Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 21 Mexico Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 22 Mexico Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 23 Mexico Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 24 Mexico Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 25 Europe Mycoplasma Testing Market, by Country, 2021 - 2033 (USD Million)
  • Table 26 Europe Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 27 Europe Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 28 Europe Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 29 Europe Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 30 Germany Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 31 Germany Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 32 Germany Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 33 Germany Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 34 UK Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 35 UK Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 36 UK Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 37 UK Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 38 France Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 39 France Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 40 France Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 41 France Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 42 Italy Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 43 Italy Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 44 Italy Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 45 Italy Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 46 Spain Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 47 Spain Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 48 Spain Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 49 Spain Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 50 Denmark Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 51 Denmark Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 52 Denmark Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 53 Denmark Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 54 Sweden Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 55 Sweden Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 56 Sweden Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 57 Sweden Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 58 Norway Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 59 Norway Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 60 Norway Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 61 Norway Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific Mycoplasma Testing Market, by Country, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 65 Asia Pacific Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 66 Asia Pacific Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 67 China Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 68 China Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 69 China Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 70 China Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 71 Japan Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 72 Japan Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 73 Japan Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 74 Japan Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 75 India Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 76 India Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 77 India Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 78 India Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 79 South Korea Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 80 South Korea Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 81 South Korea Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 82 South Korea Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 83 Australia Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 84 Australia Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 85 Australia Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 86 Australia Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 87 Thailand Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 88 Thailand Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 89 Thailand Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 90 Thailand Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 91 Latin America Mycoplasma Testing Market, by Country, 2021 - 2033 (USD Million)
  • Table 92 Latin America Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 93 Latin America Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 94 Latin America Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 95 Latin America Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 96 Brazil Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 97 Brazil Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 98 Brazil Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 99 Brazil Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 100 Argentina Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 101 Argentina Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 102 Argentina Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 103 Argentina Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 104 Middle East & Africa Mycoplasma Testing Market, by Country, 2021 - 2033 (USD Million)
  • Table 105 Middle East & Africa Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 106 Middle East & Africa Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 107 Middle East & Africa Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 108 Middle East & Africa Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 109 South Africa Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 110 South Africa Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 111 South Africa Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 112 South Africa Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 113 Saudi Arabia Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 114 Saudi Arabia Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 115 Saudi Arabia Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 116 Saudi Arabia Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 117 UAE Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 118 UAE Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 119 UAE Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 120 UAE Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)
  • Table 121 Kuwait Mycoplasma Testing Market, by Product, 2021 - 2033 (USD Million)
  • Table 122 Kuwait Mycoplasma Testing Market, by Application, 2021 - 2033 (USD Million)
  • Table 123 Kuwait Mycoplasma Testing Market, by Technology, 2021 - 2033 (USD Million)
  • Table 124 Kuwait Mycoplasma Testing Market, by End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Mycoplasma Testing Market Segmentation
  • Fig. 8 Market Snapshot, 2024
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Global Mycoplasma Testing Market: by Product Movement Analysis
  • Fig. 16 Global Mycoplasma Testing Market, for Instruments, 2021 - 2033 (USD Million)
  • Fig. 17 Global Mycoplasma Testing Market, for Kits & Reagents, 2021 - 2033 (USD Million)
  • Fig. 18 Global Mycoplasma Testing Market, for PCR Assays, 2021 - 2033 (USD Million)
  • Fig. 19 Global Mycoplasma Testing Market, for Nucleic Acid Detection Kits, 2021 - 2033 (USD Million)
  • Fig. 20 Global Mycoplasma Testing Market, for Stains, 2021 - 2033 (USD Million)
  • Fig. 21 Global Mycoplasma Testing Market, for Elimination Kits, 2021 - 2033 (USD Million)
  • Fig. 22 Global Mycoplasma Testing Market, for Standards & Controls, 2021 - 2033 (USD Million)
  • Fig. 23 Global Mycoplasma Testing Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 24 Global Mycoplasma Testing Market, for Services, 2021 - 2033 (USD Million)
  • Fig. 25 Global Mycoplasma Testing Market: Technology Movement Analysis
  • Fig. 26 Global Mycoplasma Testing Market, for PCR, 2021 - 2033 (USD Million)
  • Fig. 27 Global Mycoplasma Testing Market, for ELISA, 2021 - 2033 (USD Million)
  • Fig. 28 Global Mycoplasma Testing Market, for Direct Assay, 2021 - 2033 (USD Million)
  • Fig. 29 Global Mycoplasma Testing Market, for Indirect Assay, 2021 - 2033 (USD Million)
  • Fig. 30 Global Mycoplasma Testing Market, for Microbial Culture Techniques, 2021 - 2033 (USD Million)
  • Fig. 31 Global Mycoplasma Testing Market, for Enzymatic Methods, 2021 - 2033 (USD Million)
  • Fig. 32 Global Mycoplasma Testing Market: Application Movement Analysis
  • Fig. 33 Global Mycoplasma Testing Market, for Cell Line Testing, 2021 - 2033 (USD Million)
  • Fig. 34 Global Mycoplasma Testing Market, for Virus Testing, 2021 - 2033 (USD Million)
  • Fig. 35 Global Mycoplasma Testing Market, for End of Production Cells Testing, 2021 - 2033 (USD Million)
  • Fig. 36 Global Mycoplasma Testing Market, for Other Applications, 2021 - 2033 (USD Million)
  • Fig. 37 Global Mycoplasma Testing Market: End use Movement Analysis
  • Fig. 38 Global Mycoplasma Testing Market, for Pharmaceutical & Biotechnology Companies, 2021 - 2033 (USD Million)
  • Fig. 39 Global Mycoplasma Testing Market, for Cell Banks, 2021 - 2033 (USD Million)
  • Fig. 40 Global Mycoplasma Testing Market, for Contract Research Organizations, 2021 - 2033 (USD Million)
  • Fig. 41 Global Mycoplasma Testing Market, for Academic & Research Institutes,
  • Fig. 42 Global Mycoplasma Testing Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 43 Regional Marketplace: Key Takeaways Mycoplasma Testing Market, Region 2021 - 2033 (USD Million)
  • Fig. 44 Mycoplasma Testing Market: Regional Outlook, 2024 & 2033, 2021 - 2033 (USD Million)
  • Fig. 45 North America Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 46 U.S. Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 47 Canada Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 48 Mexico Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 49 Europe Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 50 Germany Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 51 UK Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 52 France Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 53 Italy Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 54 Spain Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 55 Denmark Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 56 Sweden Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 57 Norway Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 58 Asia Pacific Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 59 Japan Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 60 China Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 61 India Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 62 Australia Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 63 South Korea Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 64 Thailand Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 65 Latin America Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 66 Brazil Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 67 Argentina Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 68 Middle East and Africa Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 69 South Africa Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 70 Saudi Arabia Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 71 UAE Mycoplasma Testing Market, 2021 - 2033 (USD Million)
  • Fig. 72 Kuwait Mycoplasma Testing Market, 2021 - 2033 (USD Million)